BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31083092)

  • 1. Chemically Assisted Dissection With Sodium 2-Mercaptoethanesulfonate (MESNA) in the Surgical Management of Pediatric Cholesteatoma.
    de la Torre C; Villamor P
    Otol Neurotol; 2019 Jun; 40(5):645-650. PubMed ID: 31083092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemically assisted dissection by means of mesna in cholesteatoma surgery.
    Vincenti V; Magnan J; Saccardi MS; Zini C
    Otol Neurotol; 2014 Dec; 35(10):1819-24. PubMed ID: 25025536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 'chemical help' in middle-ear surgery? A systematic review on sodium 2-mercaptoethanesulfonate.
    Moffa A; Fiore V; Sabatino L; Cassano M; Tarabichi M; Kapadia M; Rinaldi V; Casale M
    J Laryngol Otol; 2021 Aug; 135(8):660-667. PubMed ID: 34219630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in biofilm in chronic cholesteatomatous otitis media in children following the application of sodium 2-mercaptoethanesulfonate (MESNA).
    de la Torre González C; Huante-Guido M; Velázquez Guadarrama N; Preciado D; Patiño López G
    Int J Pediatr Otorhinolaryngol; 2018 Jul; 110():48-52. PubMed ID: 29859586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of MESNA on the success of cholesteatoma surgery.
    Kalcioglu MT; Cicek MT; Bayindir T; Ozdamar OI
    Am J Otolaryngol; 2014; 35(3):357-61. PubMed ID: 24491375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical management of middle ear cholesteatoma in children with Turner syndrome: a multicenter experience.
    Zanetti D; Di Lella F; Negri M; Vincenti V
    Acta Biomed; 2018 Oct; 89(3):382-388. PubMed ID: 30333463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tympanoplasty, with or without mastoidectomy, is highly effective for treatment of chronic otitis media in children.
    Yoon TH; Park SK; Kim JY; Pae KH; Ahn JH
    Acta Otolaryngol Suppl; 2007 Oct; (558):44-8. PubMed ID: 17882569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A technique for concurrent procedure of mastoid obliteration and meatoplasty after canal wall down mastoidectomy.
    Kim CW; Oh JI; Choi KY; Park SM; Park MI
    Auris Nasus Larynx; 2012 Dec; 39(6):557-61. PubMed ID: 22321811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired middle ear cholesteatoma in children with cleft palate: experience from 18 surgical cases.
    Vincenti V; Marra F; Bertoldi B; Tonni D; Saccardi MS; Bacciu S; Pasanisi E
    Int J Pediatr Otorhinolaryngol; 2014 Jun; 78(6):918-22. PubMed ID: 24690221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The assesment of intraoperative use of mesna in canal wall-up cholesteatoma surgery - preliminary report.
    Pietraszek M; Bartochowska A; Wierzbicka M; Gawęcki W
    Otolaryngol Pol; 2023 Jul; 77(4):1-6. PubMed ID: 37772375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges and outcomes of cholesteatoma management in children with Down syndrome.
    Ghadersohi S; Bhushan B; Billings KR
    Int J Pediatr Otorhinolaryngol; 2018 Mar; 106():80-84. PubMed ID: 29447898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intact canal wall mastoidectomy with tympanoplasty for cholesteatoma in children.
    Dodson EE; Hashisaki GT; Hobgood TC; Lambert PR
    Laryngoscope; 1998 Jul; 108(7):977-83. PubMed ID: 9665242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of revision mastoidectomy.
    Berçin S; Kutluhan A; Bozdemir K; Yalçiner G; Sari N; Karamese O
    Acta Otolaryngol; 2009 Feb; 129(2):138-41. PubMed ID: 18607914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anatomic and functional long-term results of canal wall-down mastoidectomy.
    Kos MI; Castrillon R; Montandon P; Guyot JP
    Ann Otol Rhinol Laryngol; 2004 Nov; 113(11):872-6. PubMed ID: 15562896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canal wall down mastoidectomy with obliteration versus canal wall up mastoidectomy in primary cholesteatoma surgery.
    Wilkie MD; Chudek D; Webb CJ; Panarese A; Banhegyi G
    J Laryngol Otol; 2019 Dec; 133(12):1074-1078. PubMed ID: 31735175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of acquired cholesteatoma in patients with craniofacial anomalies: An institutional experience.
    Lourençone LFM; Batistão GT; de Cassia Rillo Dutka J; de Brito R
    Am J Otolaryngol; 2020; 41(6):102591. PubMed ID: 32634641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical treatment of middle ear cholesteatoma in children with Down syndrome.
    Bacciu A; Pasanisi E; Vincenti V; Giordano D; Caruso A; Lauda L; Bacciu S
    Otol Neurotol; 2005 Sep; 26(5):1007-10. PubMed ID: 16151350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of acquired cholesteatoma in children: a 15 year review in ENT service of CHNU de FANN Dakar.
    Diom ES; Cisse Z; Tall A; Ndiaye M; Pegbessou E; Ndiaye IC; Diallo BK; Diouf R; Diop EM
    Int J Pediatr Otorhinolaryngol; 2013 Dec; 77(12):1998-2003. PubMed ID: 24148865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cochlear effects of intraoperative use of Mesna in cholesteatoma surgery.
    Vincenti V; Magnan J; Zini C
    Acta Biomed; 2014 May; 85(1):30-4. PubMed ID: 24897967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of intraoperative findings in revision tympanomastoidectomy.
    Košec A; Kelava I; Ajduk J; Ries M; Trotić R; Bedeković V
    Am J Otolaryngol; 2017; 38(4):462-465. PubMed ID: 28431842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.